Your browser doesn't support javascript.
loading
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion protein.
Hristodorov, Dmitrij; Amoury, Manal; Mladenov, Radoslav; Niesen, Judith; Arens, Katharina; Berges, Nina; Hein, Lea; Di Fiore, Stefano; Pham, Anh-Tuan; Huhn, Michael; Helfrich, Wijnand; Fischer, Rainer; Thepen, Theo; Barth, Stefan.
Afiliación
  • Hristodorov D; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Amoury M; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Mladenov R; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Niesen J; Pharmedartis GmbH, Aachen, Germany.
  • Arens K; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Berges N; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Hein L; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Di Fiore S; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany.
  • Pham AT; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Huhn M; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany.
  • Helfrich W; Laboratory for Translational Surgical Oncology, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Fischer R; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany. Institute of Molecular Biotechnology (Biology VII), RWTH Aachen University, Aachen, Germany.
  • Thepen T; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany.
  • Barth S; Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany. Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany. stefan.barth@ime.fraunhofer.de.
Mol Cancer Ther ; 13(9): 2194-202, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24980949
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Moléculas de Adhesión Celular / Proteínas tau / Antígenos de Neoplasias / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Moléculas de Adhesión Celular / Proteínas tau / Antígenos de Neoplasias / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos